About Henry Ford Hosp. CRS
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Henry Ford Hosp. CRS
During the past decade, Henry Ford Hosp. CRS conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
2009-03-25
2012-10-18
Terminated
105
Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
2010-08-01
2013-10-01
Completed
800
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2011-02-01
2014-02-01
Completed
799
Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women
2012-10-24
2018-09-06
Completed
583
Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
2013-03-12
2018-10-03
Completed
872
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Henry Ford Hosp. CRS"
#1 collaborator was "Chiron Corporation" with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator and "AIDS Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Henry Ford Hosp. CRS
According to Clinical.Site data, the most researched conditions in "Henry Ford Hosp. CRS" are
"HIV Infections" (14 trials), "Anus Neoplasms" (1 trials), "Cardiovascular Diseases" (1 trials), "HIV Infection" (1 trials) and "Hepatitis C" (1 trials). Many other conditions were trialed in "Henry Ford Hosp. CRS" in a lesser frequency.
Clinical Trials Intervention Types at Henry Ford Hosp. CRS
Most popular intervention types in "Henry Ford Hosp. CRS" are "Drug" (9 trials), "Biological" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Darunavir" (2 trials), "Placebo" (2 trials), "Raltegravir" (2 trials), "Antiretroviral Regimens" (1 trials) and "Atazanavir" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Henry Ford Hosp. CRS
The vast majority of trials in "Henry Ford Hosp. CRS" are
14 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Henry Ford Hosp. CRS
Currently, there are NaN active trials in "Henry Ford Hosp. CRS".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 13 completed trials in Henry Ford Hosp. CRS,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Henry Ford Hosp. CRS, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".